Search
for
Sort by
Research 691–720 of 879
- Hypertrichosis of the eyelashes caused by bimatoprost
- Management of Hypotrichosis of the Eyelashes
- Trichomegaly of the eyelashes following treatment with cetuximab
- A study of normal eyelashes in Japanese individuals
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Minoxidil oral en dosis bajas en alopecia frontal fibrosante: serie de 122 pacientes
- Ritlecitinib in severe alopecia areata: a profile of its use
- Topical medication instillation techniques for glaucoma
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Dramatic and persistent loss of eyelashes
- HAIR DEPIGMENTATION AND DERMATITIS – AN UNEXPECTED PRESENTATION OF CYSTIC FIBROSIS
- Human hair morphology: a scanning electron microscopy study on a male Caucasoid and a computerized classification of regional differences.
- Trichomegaly in a 3-Year-Old Girl with Alopecia Areata
- Czy lek na jaskrę zrewolucjonizuje leczenie łysienia androgenowego? O repozycjonowaniu leku, którego efekt uboczny stał się pożądanym skutkiem terapii.
- Frontal fibrosing alopecia: A review of 60 cases
- Topical and intralesional therapies for alopecia areata
- Contact dermatitis to Minoxidil
- Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes
- Camouflage technique for alopecia areata: What is a patient to do?
- Alopecia areata: Part 2: treatment.
- Hair Diameter Variation in Different Vertical Regions of the Occipital Safe Donor Area
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Pili Annulati: A case series and proposal for classification
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- Frontal fibrosing alopecia and lichen planus pigmentosus